methyl 4-(vinylsulfonyl)benzoate | 479421-97-1

• 分子结构分类: 有机化合物 - 苯类化合物 - 苯和取代衍生物
• 英文名称: methyl 4-(vinylsulfonyl)benzoate
• 英文别名: Methyl 4-ethenylsulfonylbenzoate
• CAS: 479421-97-1
• 化学式: C₁₀H₁₀O₄S
• 分子量: 226.253
• InChiKey: XLHCEIAWCLAAGL-UHFFFAOYSA-N

物化性质

• 沸点：
  388.2±34.0 °C(Predicted)
• 密度：
  1.252±0.06 g/cm3(Predicted)

计算性质

• 辛醇/水分配系数(LogP)：
  1.8
• 重原子数：
  15
• 可旋转键数：
  4
• 环数：
  1.0
• sp3杂化的碳原子比例：
  0.1
• 拓扑面积：
  68.8
• 氢给体数：
  0
• 氢受体数：
  4

反应信息

• 作为反应物：
  描述：

  methyl 4-(vinylsulfonyl)benzoate 在 正丁基锂 、 sodium hydride 作用下， 以 四氢呋喃 、 正己烷 、 N,N-二甲基甲酰胺 为溶剂， 反应 1.0h， 生成 methyl 4-[[2-[5,6-dichloro-(1-diphenylmethyl)-2-methyl-1H-indol-3-yl]ethyl]sulfonyl]benzoate
  参考文献：
  名称：

  Inhibition of Cytosolic Phospholipase A₂α: Hit to Lead Optimization

  摘要：

  Compound I was previously reported to be a potent inhibitor of cPLA,(x in both artificial monomeric substrate and cell-based assays. However, I was inactive in whole blood assays previously used to characterize cyclooxygenase and lipoxygenase inhibitors. The IC(50) of 1 increased dramatically with cell number or lipid/detergent concentration. In an attempt to insert an electrophilic ketone between the indole and benzoic acid moieties, we discovered that increasing the distance between the two moieties gave a compound with activity in the GLU (7-hydroxycoumarinyl-gamma-linolenate) micelle assay, which contains lipid and detergent. Extensive structure-activity relationship work around this lead identified a potent pharmacophore for cPLA a inhibition. The IC(50)s between the GLU micelle and rat whole blood assays correlated highly. No correlation was found for other parameters, including lipophilicity or acidity of the required acid functionality. Compounds 25, 39, and 94 emerged as potent, selective inhibitors of cPLA(2)alpha and represent well-validated starting points for further optimization.

  DOI：

  10.1021/jm0507882
• 作为产物：
  描述：

  4-(氯磺酰基)苯甲酸甲酯 在 碳酸氢钠 、 sodium sulfite 作用下， 以 水 、 二甲基亚砜 为溶剂， 反应 26.0h， 生成 methyl 4-(vinylsulfonyl)benzoate
  参考文献：
  名称：

  使用氟甲基s盐的非对映选择性单氟环丙烷化。

  摘要：

  二芳基氟甲基s盐是氟利昂或高级氟化构件的替代品，是直接将氟亚甲基（：CHF）转移至烯烃的稳定且易于使用的来源。这些盐使得能够开发与乙烯基砜或乙烯基磺酰胺的反式单氟化Johnson-Corey-Chaykovsky反应，从而获得具有挑战性的单氟环丙烷支架。所描述的方法提供了快速进入单氟化环丙烷结构单元的途径，并具有进一步的功能化机会，可以非对映选择性地递送更复杂的合成靶标。

  DOI：

  10.1021/acs.orglett.9b02867

文献信息

• Optimized Monofluoromethylsulfonium Reagents for Fluoromethylene-Transfer Chemistry
  作者：Arturs Sperga、Renate Melngaile、Armands Kazia、Sergey Belyakov、Janis Veliks

  DOI：10.1021/acs.joc.0c02561

  日期：2021.2.19

  the properties and reactivity of fluoromethylsulfonium salts resulted in the redesign of the reagents for fluoromethylene transfer chemistry. The model reaction, fluorocyclopropanation of nitrostyrene, turned out to be a suitable platform for the discovery of more streamlined fluoromethylene transfer reagents. The incorporation of halides on one aryl ring increased the reactivity, and 2,4-dimethyl substitution

  对氟代甲基salts盐的性质和反应性的研究导致了氟代亚甲基转移化学试剂的重新设计。事实证明，模型反应（硝基苯乙烯的氟环丙烷化）是发现更多流线型氟亚甲基转移试剂的合适平台。在一个芳基环上引入卤化物可提高反应活性，而在另一个芳基环上进行2,4-二甲基取代可在试剂的反应性/结晶度和原子经济性之间取得平衡。通过开发有效的氟代环丙烷化方案以访问一系列单氟化环丙烷衍生物，证明了新试剂的实用性。
• US6500853B1
  申请人：——

  公开号：US6500853B1

  公开（公告）日：2002-12-31
• Diastereoselective Monofluorocyclopropanation Using Fluoromethylsulfonium Salts
  作者：Renate Melngaile、Arturs Sperga、Kim K. Baldridge、Janis Veliks

  DOI：10.1021/acs.orglett.9b02867

  日期：2019.9.6

  Diarylfluoromethylsulfonium salts, alternatives to freons or advanced fluorinated building blocks, are bench stable and easy-to-use sources of direct fluoromethylene (:CHF) transfer to alkenes. These salts enabled development of a trans-selective monofluorinated Johnson-Corey-Chaykovsky reaction with vinyl sulfones or vinyl sulfonamides to access synthetically challenging monofluorocyclopropane scaffolds

  二芳基氟甲基s盐是氟利昂或高级氟化构件的替代品，是直接将氟亚甲基（：CHF）转移至烯烃的稳定且易于使用的来源。这些盐使得能够开发与乙烯基砜或乙烯基磺酰胺的反式单氟化Johnson-Corey-Chaykovsky反应，从而获得具有挑战性的单氟环丙烷支架。所描述的方法提供了快速进入单氟化环丙烷结构单元的途径，并具有进一步的功能化机会，可以非对映选择性地递送更复杂的合成靶标。
• Inhibition of Cytosolic Phospholipase A₂α: Hit to Lead Optimization
  作者：John C. McKew、Megan A. Foley、Paresh Thakker、Mark L. Behnke、Frank E. Lovering、Fuk-Wah Sum、Steve Tam、Kun Wu、Marina W. H. Shen、Wen Zhang、Mario Gonzalez、Shanghao Liu、Anu Mahadevan、Howard Sard、Soo Peang Khor、James D. Clark

  DOI：10.1021/jm0507882

  日期：2006.1.1

  Compound I was previously reported to be a potent inhibitor of cPLA,(x in both artificial monomeric substrate and cell-based assays. However, I was inactive in whole blood assays previously used to characterize cyclooxygenase and lipoxygenase inhibitors. The IC(50) of 1 increased dramatically with cell number or lipid/detergent concentration. In an attempt to insert an electrophilic ketone between the indole and benzoic acid moieties, we discovered that increasing the distance between the two moieties gave a compound with activity in the GLU (7-hydroxycoumarinyl-gamma-linolenate) micelle assay, which contains lipid and detergent. Extensive structure-activity relationship work around this lead identified a potent pharmacophore for cPLA a inhibition. The IC(50)s between the GLU micelle and rat whole blood assays correlated highly. No correlation was found for other parameters, including lipophilicity or acidity of the required acid functionality. Compounds 25, 39, and 94 emerged as potent, selective inhibitors of cPLA(2)alpha and represent well-validated starting points for further optimization.